LLY

1,059.82

+3.15%↑

JNJ

214.04

+1.23%↑

ABBV

226.73

+1.47%↑

UNH

340.92

-0.14%↓

AZN

91.05

+1.4%↑

LLY

1,059.82

+3.15%↑

JNJ

214.04

+1.23%↑

ABBV

226.73

+1.47%↑

UNH

340.92

-0.14%↓

AZN

91.05

+1.4%↑

LLY

1,059.82

+3.15%↑

JNJ

214.04

+1.23%↑

ABBV

226.73

+1.47%↑

UNH

340.92

-0.14%↓

AZN

91.05

+1.4%↑

LLY

1,059.82

+3.15%↑

JNJ

214.04

+1.23%↑

ABBV

226.73

+1.47%↑

UNH

340.92

-0.14%↓

AZN

91.05

+1.4%↑

LLY

1,059.82

+3.15%↑

JNJ

214.04

+1.23%↑

ABBV

226.73

+1.47%↑

UNH

340.92

-0.14%↓

AZN

91.05

+1.4%↑

Search

Quanterix Corp

Deschisă

SectorSănătate

7.37 -2.25

Rezumat

Modificarea prețului

24h

Curent

Minim

7.26

Maxim

7.8

Indicatori cheie

By Trading Economics

Venit

-3.5M

-34M

Vânzări

16M

40M

Marjă de profit

-83.479

Angajați

471

EBITDA

5.7M

-31M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

-20.63% downside

Statistici piață

By TradingEconomics

Capitalizare de piață

115M

353M

Deschiderea anterioară

9.62

Închiderea anterioară

7.37

Sentimentul știrilor

By Acuity

55%

45%

296 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Neutral Evidence

Quanterix Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 dec. 2025, 22:53 UTC

Achiziții, Fuziuni, Preluări

Fortescue to Take Full Control of US$101 Million Copper Miner Alta

13 dec. 2025, 00:04 UTC

Achiziții, Fuziuni, Preluări

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6 Billion, Bloomberg Reports, Citing Sources

14 dec. 2025, 23:46 UTC

Market Talk

Gold Edges Higher Amid Some Tailwinds -- Market Talk

14 dec. 2025, 23:36 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

14 dec. 2025, 22:38 UTC

Achiziții, Fuziuni, Preluări

Fortescue to Take Full Control of US$101M Copper Miner Alta

14 dec. 2025, 22:02 UTC

Achiziții, Fuziuni, Preluări

Fortescue: Transaction Is Consistent With Critical Minerals Strategy

14 dec. 2025, 22:01 UTC

Achiziții, Fuziuni, Preluări

Fortescue: Alta Owns the Canariaco Project in Northern Peru

14 dec. 2025, 22:01 UTC

Achiziții, Fuziuni, Preluări

Fortescue: Alta Directors Unanimously Recommend Proposal, Will Vote in Favor

14 dec. 2025, 22:00 UTC

Achiziții, Fuziuni, Preluări

Fortescue: Agreement Implies Total Equity Value of C$139 Million

14 dec. 2025, 22:00 UTC

Achiziții, Fuziuni, Preluări

Fortescue to Pay C$1.40/Share for Securities It Does Not Already Own

14 dec. 2025, 21:59 UTC

Achiziții, Fuziuni, Preluări

Fortescue to Acquire Remaining 64% of Alta Copper

14 dec. 2025, 17:00 UTC

Câștiguri

Tonka Trucks Gambled on Keeping Production in China and Survived -- Barely -- WSJ

14 dec. 2025, 08:30 UTC

Achiziții, Fuziuni, Preluări

Kymera Had a Big Week. This Secretive Hedge Fund Bought $172 Million of Its Stock. -- Barrons.com

13 dec. 2025, 16:48 UTC

Achiziții, Fuziuni, Preluări

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 dec. 2025, 08:00 UTC

Achiziții, Fuziuni, Preluări

How the War to Win Warner Bros. Discovery Will Be Won -- Barrons.com

13 dec. 2025, 07:00 UTC

Achiziții, Fuziuni, Preluări

A Chubb/AIG Deal Could Be Good for Shareholders and a Coup for Greenberg Family -- Barrons.com

13 dec. 2025, 00:24 UTC

Achiziții, Fuziuni, Preluări

Want a Piece Of SpaceX? -- Barrons.com

12 dec. 2025, 23:49 UTC

Achiziții, Fuziuni, Preluări

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12 dec. 2025, 22:52 UTC

Market Talk

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12 dec. 2025, 22:32 UTC

Câștiguri

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 dec. 2025, 20:45 UTC

Câștiguri

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12 dec. 2025, 20:41 UTC

Market Talk

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12 dec. 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12 dec. 2025, 19:23 UTC

Câștiguri

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12 dec. 2025, 18:35 UTC

Achiziții, Fuziuni, Preluări

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12 dec. 2025, 18:33 UTC

Achiziții, Fuziuni, Preluări

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12 dec. 2025, 18:31 UTC

Market Talk

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12 dec. 2025, 17:49 UTC

Câștiguri

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12 dec. 2025, 17:34 UTC

Achiziții, Fuziuni, Preluări

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

Comparație

Modificare preț

Quanterix Corp Așteptări

Obiectiv de preț

By TipRanks

-20.63% jos

Prognoză pe 12 luni

Medie 6 USD  -20.63%

Maxim 7 USD

Minim 5 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruQuanterix Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

5.34 / 6.015Suport & Rezistență

Termen scurt

Neutral Evidence

Termen mediu

Bullish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

296 / 374 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat